Delivery Order SPE2DB25D3005-SPE2DB25FQFBH

Award Date 5/13/25
Potential Completion Date 6/4/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,568,078,577 units of the prescription medication YONSA 125 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the delivery of 4,567,957,294 units of the prescription drug YONSA 125 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,957,350 units of the prescription medication YONSA 125 MG TABLET 120S, with a ceiling value of $2,271.36. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance ending on May 8, 2025. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, under a firm-fixed-price contract with a ceiling value of $2,195.48. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug YONSA 125 MG TABLET 120S. The contract has a ceiling value of $2,195.48 and a period of performance through July 9, 2024. It is a firm fixed-price contract, classified as a delivery order and not designated with any set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price arrangement. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,628.16 firm fixed-price contract is for the supply of YONSA 125 MG TABLET 120S, a type of prescription medication. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,195.48 firm-fixed-price contract is for the delivery of 4,565,965,358 units of YONSA 125 MG Tablet 120S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products and drugs to various government agencies and healthcare...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQFBH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the supply of 4,568,235,544 units of the prescription medication YONSA 125 MG TABLET 120S. The delivery order is a firm fixed-price contract with a completion date of June 4, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract has no set-aside designation, indicating open competition. As a major pharmaceutical distributor and federal contractor, AmerisourceBergen Drug Corp is positioned as a critical vendor in supporting the DLA's and other government agencies' medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/12/25, 12:17 PM